Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2004 | 1 |
2008 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
Int J Mol Sci. 2023 Jul 11;24(14):11297. doi: 10.3390/ijms241411297.
Int J Mol Sci. 2023.
PMID: 37511057
Free PMC article.
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.
Lejeune M, Reverté L, Sauras E, Gallardo N, Bosch R, Roso A, Petit A, Peg V, Riu F, García-Fontgivell J, Ibáñez J, Relea F, Vieites B, Bor C, de la Cruz-Merino L, Arenas M, Rodriguez V, Galera J, Korzynska A, Belhomme P, Plancoulaine B, Álvaro T, López C.
Lejeune M, et al. Among authors: riu f.
Cancers (Basel). 2023 Jan 18;15(3):597. doi: 10.3390/cancers15030597.
Cancers (Basel). 2023.
PMID: 36765559
Free PMC article.
Item in Clipboard
Circulating blood cells modulate the atherosclerotic process in apolipoprotein E-deficient mice.
Tous M, Ferré N, Vilella E, Riu F, Camps J, Joven J.
Tous M, et al. Among authors: riu f.
Metabolism. 2004 Jan;53(1):95-100. doi: 10.1016/j.metabol.2003.08.012.
Metabolism. 2004.
PMID: 14681849
Item in Clipboard
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM; GEICAM 9906 Study Investigators.
Martín M, et al.
J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27.
J Natl Cancer Inst. 2008.
PMID: 18505968
Free article.
Clinical Trial.
Item in Clipboard
Pathologic changes related to CMF primary chemotherapy in breast cancer. Pathological evaluation of response predicts clinical outcome.
Moreno A, Escobedo A, Benito E, Serra JM, Gumà A, Riu F.
Moreno A, et al. Among authors: riu f.
Breast Cancer Res Treat. 2002 Sep;75(2):119-25. doi: 10.1023/a:1019607924403.
Breast Cancer Res Treat. 2002.
PMID: 12243504
Clinical Trial.
Item in Clipboard
Cite
Cite